Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Gilead-Sciences
Company Monitoring Page for Gilead-Sciences
latest headlines for company on cafepharma
Gilead Judge Re-Opens Case Amid Claim Merck Scientist Lied
Bloomberg
Sat, 04/30/16 - 10:41 am
Tags:
Gilead Sciences
,
Merck
,
hepatitis C
,
Harvoni
,
Sovaldi
Gilead 1Q profit tumbles on slower hepatitis C drug sales
Yahoo/AP
Thu, 04/28/16 - 05:57 pm
Tags:
Gilead Sciences
,
earnings
Gilead Earnings Outlook
Seeking Alpha
Thu, 04/28/16 - 09:44 am
Tags:
Gilead Sciences
,
earnings
Seven New York insurers end restrictions on coverage for hepatitis C drugs
BioPharma Dive
Wed, 04/27/16 - 09:20 am
Tags:
New York
,
insurers
,
hepatitis C
,
Merck
,
Zepatier
,
Gilead Sciences
,
Harvoni
Can Humira Still Dominate In 2022?
Seeking Alpha
Thu, 04/21/16 - 03:28 pm
Tags:
Humira
,
Amgen
,
Bristol-Myers Squibb
,
Coherus Biosciences
,
Gilead Sciences
,
Intercept Pharma
,
JNJ
,
Novartis
,
Pfizer
Is Gilead Headed Even Higher?
TheStreet.com
Thu, 04/21/16 - 08:46 am
Tags:
Gilead Sciences
Why Biotech Will Benefit from Higher Drug Prices
Barron's
Wed, 04/20/16 - 06:41 pm
Tags:
biotech
,
drug pricing
,
JNJ
,
Gilead Sciences
,
Amgen
,
Biogen
New analysis boosts cost-effectiveness argument for Merck's Zepatier
BioPharma Dive
Wed, 04/20/16 - 06:37 pm
Tags:
Merck
,
Zepatier
,
hepatitis C
,
Harvoni
,
Gilead Sciences
Merck's 'no patient left behind' approach to hepatitis C
BioPharma Dive
Mon, 04/18/16 - 09:00 pm
Tags:
Merck
,
hepatitis C
,
Zepatier
,
Gilead Sciences
,
Sovaldi
,
Harvoni
Medivation: It’s Not Just M&A
Barron's
Mon, 04/18/16 - 10:15 am
Tags:
Medivation
,
M&A
,
AstraZenca
,
Sanofi
,
Gilead Sciences
,
talazoparib
,
PARP inhibitors
Gilead Sciences' Two Phase Three Trials Meet Primary Endpoints
Yahoo/Benzinga
Fri, 04/15/16 - 09:00 am
Tags:
Gilead Sciences
,
clinical trials
,
TAF
,
hepatitis B
This is the most expensive drug in America
Marketwatch
Thu, 04/14/16 - 09:22 pm
Tags:
Gilead Sciences
,
Sovaldi
,
drug pricing
,
hepatitis C
Will Gilead Sciences, Inc (GILD) Shock Everyone With Earnings This Quarter
Bidness, ETC
Wed, 04/13/16 - 09:57 am
Tags:
Gilead Sciences
,
earnings
Medivation: Biotech’s Most Wanted?
Barron's
Wed, 04/13/16 - 09:53 am
Tags:
Medivation
,
M&A
,
Amgen
,
Gilead Sciences
,
Sanofi
,
AstraZeneca
Biotech: If M&A is the Answer, What’s the Question?
Barron's
Tue, 04/12/16 - 03:42 pm
Tags:
biotech
,
M&A
,
Amgen
,
Biogen
,
Celgene
,
Gilead Sciences
The FDA Just Approved Another Next-Gen Gilead HIV Drug
Fortune
Tue, 04/5/16 - 10:28 pm
Tags:
FDA
,
Descovy
,
Gilead Sciences
,
HIV
Why Gilead Sciences and Amgen Can Eye Medivation As Acquisition Target
Bidness, ETC
Tue, 04/5/16 - 08:48 am
Tags:
Gilead Sciences
,
Amgen
,
Medivation
,
M&A
Gilead bags early-stage NASH drug in $1.2B Nimbus deal
Fierce Biotech
Mon, 04/4/16 - 09:48 am
Tags:
Gilead Sciences
,
NASH
,
Nimbus
Patent Palooza: One Patent Battle in Hep C, And Another Patent Brawl Brewing On Capitol Hill
Motley Fool
Mon, 04/4/16 - 07:59 am
Tags:
patents
,
hepatitis C
,
Medivation
,
Xtandi
,
Merck
,
Ionis Pharmaceuticals
,
Gilead Sciences
How Big of a Deal Are Gilead Sciences Patent Woes?
Motley Fool
Fri, 04/1/16 - 10:04 pm
Tags:
Gilead Sciences
,
patents
,
Merck
,
Ionis Pharmaceuticals
,
hepatitis C
Pages
« first
‹ previous
…
52
53
54
55
56
57
58
59
60
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.